Combined detection of sST2 and hs-cTnT in plasma improves the diagnostic efficacy of clinical outcomes in HF patients with and without DM (AUC = 0.811) and is significantly superior to single markers. This evidence concerns the gene TNNT2 and diabetes mellitus.